Hiroaki Iwamoto Selected Research

Hiroaki Iwamoto Research Topics

Disease

33	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 02/2016
22	Neoplasms (Cancer) 04/2024 - 05/2016
13	Neoplasm Metastasis (Metastasis) 02/2024 - 10/2016
7	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 05/2016
4	Urologic Neoplasms (Urological Cancer) 02/2024 - 01/2022
3	Sarcopenia 06/2023 - 05/2021
3	Neutropenia 01/2023 - 07/2018
3	Carcinoma (Carcinomatosis) 11/2021 - 10/2016
2	Hypotension (Low Blood Pressure) 04/2024 - 11/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2023 - 05/2023
2	COVID-19 01/2023 - 04/2022
2	Kidney Neoplasms (Kidney Cancer) 11/2022 - 12/2021
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 07/2018
1	Urinary Bladder Calculi (Bladder Calculi) 03/2024
1	Bacterial Infections (Bacterial Infection) 02/2024
1	Non-Muscle Invasive Bladder Neoplasms 06/2023
1	Hypoalbuminemia 06/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Febrile Neutropenia 01/2023
1	Pneumoperitoneum 09/2022
1	Embolism (Embolus) 09/2022
1	Air Embolism (Gas Embolism) 09/2022
1	Urinary Incontinence 06/2022
1	Erectile Dysfunction 06/2022
1	Hemorrhage 06/2022
1	Microsatellite Instability 01/2022
1	Small Cell Carcinoma 01/2022
1	Stroke (Strokes) 01/2022
1	Pathologic Complete Response 01/2022
1	Lymphocele 09/2021
1	Pelvic Organ Prolapse 01/2021
1	Cachexia 01/2021
1	Anorexia 01/2021
1	Leukopenia 08/2020
1	Hypertension (High Blood Pressure) 07/2020
1	Disease Progression 02/2020
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2020

Drug/Important Bio-Agent (IBA)

10	AndrogensIBA 06/2023 - 02/2016
7	LigandsIBA 11/2022 - 02/2016
6	Androgen Receptors (Androgen Receptor)IBA 04/2023 - 02/2016
6	Prostate-Specific Antigen (Semenogelase)IBA 11/2022 - 02/2016
5	cabazitaxel FDA Link 06/2023 - 03/2018
5	CC ChemokinesIBA 11/2022 - 02/2016
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2016
4	Docetaxel (Taxotere)FDA Link 06/2023 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 02/2016
3	Hormones (Hormone)IBA 03/2023 - 03/2021
2	AcidsIBA 04/2024 - 11/2019
2	Indicators and Reagents (Reagents)IBA 05/2023 - 01/2022
2	pembrolizumabIBA 04/2022 - 01/2022
2	Therapeutic UsesIBA 01/2022 - 04/2020
2	Coffee FDA Link 12/2021 - 01/2019
2	DiterpenesIBA 12/2021 - 01/2019
2	cafestolIBA 12/2021 - 01/2019
2	kahweol acetateIBA 12/2021 - 01/2019
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 03/2019
2	pegfilgrastim (Neulasta)FDA Link 01/2021 - 07/2018
2	Testosterone (Sustanon)FDA Link 01/2021 - 01/2020
2	Gemcitabine FDA Link 08/2019 - 01/2019
2	ChemokinesIBA 01/2019 - 03/2018
1	ProcalcitoninIBA 02/2024
1	Procollagen Type IIBA 01/2024
1	Tartrate-Resistant Acid PhosphataseIBA 01/2024
1	Chalcone (Benzalacetophenone)IBA 06/2023
1	AlbuminsIBA 06/2023
1	Small Interfering RNA (siRNA)IBA 04/2023
1	Carbon DioxideIBA 09/2022
1	COVID-19 VaccinesIBA 04/2022
1	VaccinesIBA 04/2022
1	kahweolIBA 12/2021
1	PlatinumIBA 11/2021
1	2'-hydroxyflavanoneIBA 01/2021
1	indium-bleomycinIBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	testosterone enanthate (Delatestryl)FDA LinkGeneric 01/2021
1	FlavonoidsIBA 01/2021
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2021
1	taxaneIBA 01/2021
1	Chemokine ReceptorsIBA 12/2020
1	Antihypertensive Agents (Antihypertensives)IBA 07/2020

Therapy/Procedure

20	Castration 03/2024 - 03/2018
16	Therapeutics 06/2023 - 01/2020
11	Drug Therapy (Chemotherapy) 01/2023 - 10/2016
5	Transurethral Resection of Bladder 04/2024 - 09/2022
4	Oral Administration 04/2024 - 01/2019
4	Nephrectomy 06/2023 - 06/2022
4	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 01/2019
4	Radiotherapy 04/2022 - 05/2016
4	Combination Drug Therapy (Combination Chemotherapy) 11/2021 - 01/2019
3	Brachytherapy 03/2024 - 01/2020
2	General Anesthesia 04/2024 - 11/2019
2	Lymph Node Excision (Lymph Node Dissection) 04/2022 - 09/2021
1	Spinal Anesthesia 04/2024
1	Cystectomy 02/2024
1	Patient Readmission 02/2024
1	Conservative Treatment 02/2024
1	Hand Hygiene 01/2023
1	Cryosurgery 11/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2022